October 16, 2019 - Issue: Vol. 165, No. 163 — Daily Edition116th Congress (2019 - 2020) - 1st Session
All in House sectionPrev44 of 99Next
ONDCP TECHNICAL CORRECTIONS ACT OF 2019; Congressional Record Vol. 165, No. 163
(House of Representatives - October 16, 2019)
Text available as:
Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.
[Pages H8165-H8167] From the Congressional Record Online through the Government Publishing Office [www.gpo.gov] ONDCP TECHNICAL CORRECTIONS ACT OF 2019 Mr. ROUDA. Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 3889) to amend the Office of National Drug Control Policy Reauthorization Act of 1998 to make technical corrections, as amended. The Clerk read the title of the bill. The text of the bill is as follows: H.R. 3889 Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``ONDCP Technical Corrections Act of 2019''. SEC. 2. TECHNICAL CORRECTIONS. (a) Office of National Drug Control Policy Reauthorization Act of 1998 Technical Corrections.--The Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1701 et seq.) is amended-- (1) by striking ``National Drug Control Program Agency'' and inserting ``National Drug Control Program agency'' each place it appears; (2) by striking ``National Drug Control Program Agencies'' and inserting ``National Drug Control Program agencies'' each place it appears; (3) in section 702(15), by striking ``tribal'' each place it appears and inserting ``Tribal''; (4) in section 703-- (A) in subsection (a)-- (i) in paragraph (4), by striking ``program,'' and inserting ``programs,''; and (ii) in paragraph (6), by striking ``High-Intensity'' and inserting ``High Intensity''; and (B) in subsection (d), by striking ``chapter'' each place it appears and inserting ``title''; (5) in section 704-- (A) in subsection (a)(1)-- (i) in subparagraph (C)-- (I) in clause (i), by striking ``section 704(c)(4)'' and inserting ``subsection (c)(5)''; and (II) in clause (iv), by striking ``section 704(j)'' and inserting ``subsection (j)''; and (ii) in subparagraph (D)-- (I) by striking ``The Director shall determine whether the coordinator position is a noncareer'' and inserting ``For purposes of carrying out the previous sentence, the Director shall designate or appoint an''; and (II) by striking ``a career'' and inserting ``an''; (B) in subsection (b)(21)(A)(iii), by striking ``chapter'' and inserting ``title''; (C) in subsection (c)-- (i) in paragraph (2)(A)(ii), by striking ``fo'' and inserting ``of''; (ii) in paragraph (3)(E)(ii)-- (I) in subclause (I), by striking ``subparagraph (A)'' and inserting ``clause (i)''; and (II) in subclause (II), by striking ``clause (i)'' and inserting ``subclause (I)''; and (iii) in paragraph (5)(B)-- (I) by striking ``The Director shall determine whether the coordinator position is a noncareer'' and inserting ``For purposes of carrying out subparagraph (A), the Director shall designate or appoint an''; and (II) by striking ``a career'' and inserting ``an''; (D) in subsection (d)-- (i) paragraph (8)-- (I) in subparagraph (E)-- (aa) in clause (iii), by moving subclauses (I) through (V) two ems to the left so that the left margin of such clause is aligned with the margin of clause (iii); (bb) by moving clause (iii) two ems to the left so that the left margin of such clause is aligned with the margin of subparagraph (E); and (cc) by redesignating clause (iii) as subparagraph (F); and (II) in subparagraph (F), as so redesignated-- [[Page H8166]] (aa) by redesignating subclauses (I) through (V) as clauses (i) through (v), respectively; and (bb) in clause (v), as so redesignated, by striking the period at the end and inserting a semicolon; and (ii) in paragraph (9), by striking ``section 704(f)(5);'' and inserting ``subsection (f)(5); and''; and (E) in subsection (j)-- (i) by striking ``The Director shall determine whether the coordinator position is a noncareer'' and inserting ``For purposes of carrying out the previous sentence, the Director shall designate or appoint an''; (ii) by striking ``a career'' and inserting ``an''; and (iii) by inserting ``section'' before ``706''; (6) in section 705-- (A) in subsection (d)(1), by striking ``that every'' and inserting ``than every''; and (B) in subsection (f)-- (i) in paragraph (1)-- (I) in subparagraph (A)(i), by striking the semicolon at the end and inserting ``; and''; and (II) in subparagraph (C)-- (aa) by inserting ``that may impede applicants'' after ``barriers''; and (bb) by striking ``impediments'' and all that follows through ``agencies''; and (ii) in paragraph (2), in the heading, by striking ``drug control'' and inserting ``drug control program''; (7) in section 707(o)(2)(B), by striking ``802(33))'' and inserting ``802(33)))''; and (8) in section 709-- (A) in subsection (a)-- (i) in the heading, by inserting ``and Continuing'' before ``Threats''; (ii) by striking ``The Director shall determine whether the coordinator position is a noncareer'' and inserting ``For purposes of carrying out the previous sentence, the Director shall designate or appoint an''; and (iii) by striking ``a career'' and inserting ``an''; (B) in subsection (d)-- (i) in paragraph (3)(F), by striking ``response of'' and inserting ``response to''; and (ii) in paragraph (4)(B)(iii), by inserting ``the'' before ``plan, where''; and (C) in subsection (f)(1), by striking ``subtitle'' and inserting ``subsection''. (b) Repeal of Annual Report Requirement.--The Office of National Drug Control Policy Reauthorization Act of 2006 (Public Law 109-469; 120 Stat. 3502) is amended-- (1) by repealing section 203; and (2) in section 1(c), in the table of contents, by striking the item relating to section 203. (c) Technical Correction to the Substance Abuse Prevention Act of 2018.-- (1) Amendments.--The Substance Abuse Prevention Act of 2018 (subtitle K of title VIII of Public Law 115-271) is amended-- (A) in section 8203-- (i) in subsection (a)-- (I) in the heading, by striking ``National Narcotics Leadership Act of 1988'' and inserting ``Anti-Drug Abuse Act of 1988''; (II) in paragraph (1), by striking ``the National Narcotics Leadership Act of 1988'' and inserting ``subtitle A of title I of the Anti-Drug Abuse Act of 1988''; (III) by striking paragraph (3); (IV) by redesignating paragraph (4) as paragraph (3); and (V) in paragraph (3)(A), as so redesignated, by striking ``National Narcotics Leadership Act of 1988'' and inserting ``Anti-Drug Abuse Act of 1988''; (ii) in subsection (b)-- (I) in the heading, by striking ``National Narcotics Leadership Act of 1988'' and inserting ``Anti-Drug Abuse Act of 1988''; (II) in the matter preceding paragraph (1), by striking ``National Narcotics Leadership Act of 1988'' and inserting ``Anti-Drug Abuse Act of 1988''; and (III) in paragraph (4)(B), by striking ``in section 1032(b)(1)(A) (21 U.S.C. 1532(b)(1)(A)), by striking clause (iii) and inserting the following'' and inserting ``by amending section 1032(b)(3)(D) (21 U.S.C. 1532(b)(3)(D)) to read as follows''; and (iii) in the quoted matter added by subsection (b)(4)(B)-- (I) in clause (iii), by moving subclauses (I) and (II) two ems to the left so that the left margins of such subclauses are aligned with the margin of clause (iii); (II) by moving clause (iii) two ems to the left so that the left margin of such clause is aligned with the margin of subparagraph (B) of subsection (b)(4); (III) by redesignating clause (iii) as subparagraph (D); and (IV) in subparagraph (D), as so redesignated-- (aa) by redesignating subclauses (I) and (II) as clauses (i) and (ii), respectively; and (bb) in clause (ii), as so redesignated, by striking ``tears'' and inserting ``years''; and (B) in section 8221-- (i) in the quoted matter added by subsection (a), by striking ```sec. 706. national drug control strategy.''; and (ii) in subsection (a), by striking ``amended to read as follows:'' and inserting ``amended-- ``(1) by striking subsections (a) and (b); ``(2) by redesignating subsections (c) and (d) as subsections (h) and (i), respectively; and ``(3) by inserting before subsection (h), as so redesignated, the following:''. (2) Effective date.--The amendments made by this subsection shall take effect as if included in the enactment of the Substance Abuse Prevention Act of 2018 (subtitle K of title VIII of Public Law 115-271). (3) Matching requirement revived and restored.--Section 1032(b)(1)(A)(iii) of the Anti-Drug Abuse Act of 1988 (21 U.S.C. 1532(b)(1)(A)) is revived and restored as if the amendment made by section 8203(b)(4) of the Substance Abuse Prevention Act of 2018 (subtitle K of title VIII of Public Law 115-271) had never been enacted. (d) Additional Technical Corrections to the Office of National Drug Control Policy Reauthorization Act of 1998.-- Section 706 of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1701 et seq.) is amended-- (1) in subsection (c)(1)(N)-- (A) in clause (ii), by striking ``Programs'' and inserting ``Program agencies''; and (B) in clause (iii), by striking ``Agencies'' and inserting ``Program agencies''; (2) in subsection (c)(2), in the matter preceding subparagraph (A), by striking ``paragraph (1)'' and inserting ``paragraph (1)(M)''; (3) in subsection (f)-- (A) in paragraph (2), by striking ``office'' and inserting ``Office''; and (B) in paragraph (3)(A)(ii)-- (i) in subclause (III), by striking the semicolon at the end and inserting ``; and''; and (ii) in subclause (IV), by striking the semicolon at the end and inserting a period; and (4) in subsection (g)(3), in subparagraph (B), by striking ``chapter;'' and inserting ``title;''. (e) Administration of Grant.--Section 4 of Public Law 107- 82 (21 U.S.C. 1521 note) is amended-- (1) in subsection (a)-- (A) by striking ``The Director'' and inserting ``Beginning in fiscal year 2020, the Director''; and (B) by striking ``, using amounts authorized to be appropriated by subsection (d),''; and (2) by amending subsection (d) to read as follows: ``(d) Administration of Grant.-- ``(1) Duration.--With respect to a grant made under subsection (a) in fiscal year 2020, the term of the grant shall be 4 years. ``(2) Disbursement.--To the extent amounts are provided in appropriation Acts for such grant, the Director shall disburse the amount of the grant made under subsection (a) on an annual basis.''. The SPEAKER pro tempore. Pursuant to the rule, the gentleman from California (Mr. Rouda) and the gentleman from Arizona (Mr. Gosar) each will control 20 minutes. The Chair recognizes the gentleman from California. General Leave Mr. ROUDA. Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material on this measure. The SPEAKER pro tempore. Is there objection to the request of the gentleman from California? There was no objection. Mr. ROUDA. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I am proud to support this bipartisan legislation that will make technical changes to the reauthorization of the Office of National Drug Control Policy included in last year's SUPPORT Act. As we all know, we are in the midst of a substance use disorder epidemic fueled by the proliferation of opioids, exacerbated by synthetic opioids like fentanyl, and increased use of methamphetamines, among other threats. This year, Americans will lose close to 70,000 friends and family and loved ones due to drug overdoses. More Americans are now dying annually due to overdose than at the height of the AIDS crisis or during the entire Vietnam war. No community is unaffected by the crisis. In my home of Orange County, California, drug and alcohol overdose deaths have increased by 82 percent since 2000. Across our country, our constituents are asking us to advance solutions to address this epidemic. Last year, Congress passed and President Trump signed the SUPPORT for Patients and Communities Act, a wide-ranging, bipartisan bill aimed at addressing treatment, prevention, recovery, and enforcement. The SUPPORT Act represents an important step in the right direction to reverse the tide of overdose deaths. The SUPPORT Act included provisions to reauthorize and reform the Office of National Drug Control Policy, a component of the Executive Office of the President. ONDCP plays a critical role in overseeing the Federal Government's drug control efforts. However, there were several technical issues in the SUPPORT Act that must be corrected to ensure that the office can properly carry out its duties as Congress intended and improve the Federal Government's response to this crisis. [[Page H8167]] The ONDCP Technical Corrections Act of 2019 would ensure the integrity of the performance measurement system, help ONDCP hire the best people to address the addiction crisis, and improve the effectiveness of grant programs. These corrections would help ONDCP's efficient and effective execution of its mission: preventing, combating, and treating the effects of drug proliferation throughout our Nation. I thank the gentleman from North Carolina (Mr. Meadows), my fellow Member, for joining me in introducing this bill and the committee staff on both sides of the aisle for working diligently to develop and advance it. I look forward to the House of Representatives passing this bill today. There is much more to be done to address the addiction crisis, and I look forward to continued work with all of my colleagues on this important issue. Mr. Speaker, I reserve the balance of my time. House of Representatives, Committee on Energy and Commerce, Washington, DC, October 15, 2019. Hon. Elijah E. Cummings, Chair, Committee on Oversight and Reform, Washington, DC. Dear Chairman Cummings: I write concerning H.R. 3889, the ``ONDCP Technical Corrections Act of 2019,'' which was additionally referred to the Committee on Energy and Commerce. In recognition of the desire to expedite consideration of H.R. 3889, the Committee on Energy and Commerce agrees to waive formal consideration of the bill as to provisions that fall within the Rule Xjurisdiction of the Committee on Energy and Commerce. The Committee takes this action with the mutual understanding that we do not waive any jurisdiction over the subject matter contained in this or similar legislation, and that the Committee will be appropriately consulted and involved as this bill or similar legislation moves forward so that we may address any remaining issues within our jurisdiction. I also request that you support my request to name members of the Committee on Energy and Commerce to any conference committee to consider such provisions. Finally, I would appreciate the inclusion of this letter into the Congressional Record during floor consideration of H.R. 3889. Sincerely, Frank Pallone, Jr., Chairman. ____ House of Representatives, Committee on Oversight and Reform, Washington, DC, October 16, 2019. Hon. Frank Pallone, Jr., Chairman, Committee on Energy and Commerce, House of Representatives, Washington, DC. Dear Chairman Pallone: Thank you for your letter regarding H.R. 3889, the ONDCP Technical Corrections Act of 2019. As you know, the bill was referred primarily to the Committee on Oversight and Reform with an additional referral to the Committee on Energy and Commerce. I thank you for allowing the Committee on Energy and Commerce to be discharged from further consideration of the bill to expedite floor consideration. This discharge in no way affects your jurisdiction over the subject matter of the bill, and it will not serve as precedent for future referrals. In addition, should a conference on the bill be necessary, I would support your request to have the Committee on Energy and Commerce represented on the conference committee. I would be pleased to include this letter and any response in the Congressional Record during floor consideration to memorialize our understanding. Sincerely, Elijah E. Cummings, Chairman. Mr. GOSAR. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in support of H.R. 3889, the ONDCP Technical Corrections Act of 2019. Simply, this bill makes technical amendments to a law we passed last Congress. We moved quickly last Congress to reauthorize the Office of National Drug Control Policy. The reauthorization was drafted to reinvigorate the office and give the Trump administration additional authorities to address the opioid crisis. Last Congress, the Committee on Oversight and Reform worked across party lines on a policy solution. President Trump appointed Jim Carroll to lead that office. The Senate confirmed his nomination earlier this year. Since then, Director Carroll has twice testified before the Committee on Oversight and Reform about the good work the administration is doing to combat the crisis. This bill will help to further support this administration's good work. I want to congratulate the gentleman from California (Mr. Rouda) for his good work on this bill, and I urge my colleagues to support it. Mr. Speaker, I yield back the balance of my time. Mr. ROUDA. Mr. Speaker, I yield back the balance of my time. The SPEAKER pro tempore. The question is on the motion offered by the gentleman from California (Mr. Rouda) that the House suspend the rules and pass the bill, H.R. 3889, as amended. The question was taken; and (two-thirds being in the affirmative) the rules were suspended and the bill, as amended, was passed. A motion to reconsider was laid on the table. ____________________
All in House sectionPrev44 of 99Next